tradingkey.logo
tradingkey.logo
Search

Forte Biosciences Announces Positive Data In Fb102 Celiac Disease Phase 1B Study

ReutersJun 23, 2025 11:18 AM
facebooktwitterlinkedin

- Forte Biosciences Inc FBRX.O:

  • FORTE BIOSCIENCES ANNOUNCES POSITIVE DATA IN FB102 CELIAC DISEASE PHASE 1B STUDY

  • FORTE BIOSCIENCES INC - FB102 SHOWS SIGNIFICANT BENEFIT ON VCIEL ENDPOINT

  • FORTE BIOSCIENCES INC - FB102 SHOWS DECLINE IN CD3-POSITIVE T CELLS DENSITY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI